Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Flex Pharma’s cramp study fails, shares plunge; FDA makes Egalet wait on pain drug
Flex Pharma’s cramp study fails, shares plunge; FDA makes Egalet wait on pain drug
Flex Pharma’s cramp study fails, shares plunge; FDA makes Egalet wait on pain drug
Submitted by
admin
on October 14, 2016 - 11:52am
Source:
Endpoints
News Tags:
Flex Pharma
FDA
Egalet
FLX-787
leg cramps
Arymo ER
opioids
Headline:
Flex Pharma’s cramp study fails, shares plunge; FDA makes Egalet wait on pain drug
Do Not Allow Advertisers to Use My Personal information